Role of presepsin in the diagnosis of late-onset neonatal sepsis in preterm infants

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 29, Issue 11, 2016, Pages 1834-1839

  Topcuoglu, Sevilay ^a   Arslanbuga, Cansev ^b   Gursoy, Tugba ^c   Aktas, Alev ^a   Karatekin, Guner ^a   Uluhan, Ramazan ^b   Ovali, Fahri ^a  

^a Neonatal Intensive Care Unit   (Turkey)

^b Zeynep Kamil Maternity and Child Research and Training Hospital   (Turkey)

^c KOÇ UNIVERSITY   (Turkey)

Author keywords

Late onset sepsis; newborn; premature; presepsin

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PRESEPSIN; PROCALCITONIN; UNCLASSIFIED DRUG; CD14 ANTIGEN; PEPTIDE FRAGMENT; PRESEPSIN PROTEIN, HUMAN;

AREA UNDER THE CURVE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LATE ONSET NEONATAL SEPSIS; MALE; NEWBORN SEPSIS; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RELIABILITY; SENSITIVITY AND SPECIFICITY; BLOOD; CLINICAL TRIAL; NEWBORN; SEPSIS;

ANTIGENS, CD14; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; SEPSIS;

EID: 84938832977     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2015.1064885     Document Type: Article

References (31)

1. Downey LC, Smith PB, Benjamin Jr DK. Risk factors and prevention of late-onset sepsis in premature infants. Early Hum Dev 2010;86:7-12.
2. Stoll BJ, Hansen NI, Bell EF, et al. Eunice Kennedy Shriver National Institute of child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126:443-56.
3. Meadow W, Frain L, Ren Y, et al. Serial assessment of mortality in the neonatal intensive care unit by algorithm and intuition: certainty, uncertainty, and informed consent. Pediatrics 2002;109: 878-86.
4. Connell TG, Rele M, Cowley D, et al. How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 2007;119: 891-6.
5. Kellogg JA, Ferrentino FL, Goodstein MH, et al. Frequency of low level bacteremia in infants from birth to two months of age. Pediatr Infect Dis J 1997;16:381-5.
6. Edgar JD, Gabriel V, Gallimore JR, et al. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal in-fection. BMC Pediatr 2010;10:22.
7. Newman TB, Puopolo KM, Wi S, et al. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010;126:903-9.
8. Wu TW, Tabangin M, Kusano R, et al. The utility of serum hepcidin as a biomarker for late-onset neonatal sepsis. J Pediatr 2013;162:67-71.
9. Bas S, Gauthier BR, Spenato U, et al. CD14 is an acute-phase protein. J Immunol 2004;172:4470-9.
10. Mussap M, Noto A, Fravega M, Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med 2011;24: 12-14.
11. Rey Nores JE, Bensussan A, Vita N, et al. Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol 1999;29:265-76.
12. Shozushima T, Takahashi G, Matsumoto N, et al. Usefulness of 12. presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 2011;17: 764-9.
13. Endo S, Suzuki Y, Takahashi G, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012;18:891-7.
14. Masson S, Caironi P, Spanuth E, et al; ALBIOS Study Investigators. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care 2014;18:R6.
15. Mussap M, Puxeddu E, Burrai P, et al. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges. J Matern Fetal Neonatal Med 2012;25:51-3.
16. Casani A, Cocca F, Coletta C, et al. Presepsin values in healthy mature and near-term neonates using a new immunoassay: a preliminary study. JPNIM 2012;1:152.
17. Puxeddu E, Noto A, Mussap M, et al. Is soluble CD14 subtype (sCD14-ST) presepsin an early biomarker of neonatal sepsis? Yes it is. J Pediatr Neonat Individualized Med 2012;1:159.
18. Poggi C, Bianconi T, Gozzini E, et al. Presepsin for the detection of late-onset sepsis in preterm newborns. Pediatrics 2015;135:68-75.
19. Ballard JL, Khoury JC, Wedig K, et al. New Ballard score, expanded to include extremely premature infants. J Pediatr 1991; 119:417-23.
20. Töllner U. Early diagnosis of septicemia in the newborn. Clinical studies and sepsis score. Eur J Pediatr 1982;138:331-7.
21. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2-8.
22. Haque KN. Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med 2005;6:45-9.
23. Nissen MD. Congenital and neonatal pneumonia. Paediatr Respir Rev 2007;8:195-203.
24. Ku LC, Boggess KA, Cohen-Wolkowiez M. Bacterial meningitis in infants. Clin Perinatol 2015;42:29-45.
25. Auriti C, Fiscarelli E, Ronchetti MP, et al. Procalcitonin in detecting neonatal nosocomial sepsis. Arch Dis Child Fetal Neonatal Ed 2012;97:368-70.
26. Ulla M, Pizzolato E, Lucchiari M, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care 2013; 17:168.
27. Liu B, Chen YX, Yin Q, et al. Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department. Crit Care 2013;17:244-56.
28. Verboon-Maciolek MA, Thijsen SF, Hemels MA, et al. Inflammatory mediators for the diag-nosis and treatment of sepsis in early infancy. Pediatr Res 2006;59:457-61.
29. Behnes M, Bertsch T, Lepiorz D, et al. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care 2014;18:507-20.
30. Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillancenetwork. Arch Dis Child Fetal Neonatal Ed 2011;96:9-14.
31. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285-91.